Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Treasury Shares: 2011-2025

Historic Treasury Shares for Abeona Therapeutics (ABEO) over the last 8 years, with Sep 2025 value amounting to $4.1 million.

  • Abeona Therapeutics' Treasury Shares rose 25.00% to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 million, marking a year-over-year increase of 25.00%. This contributed to the annual value of $3.3 million for FY2024, which is 35.64% up from last year.
  • Per Abeona Therapeutics' latest filing, its Treasury Shares stood at $4,000 for Q3 2014, which was down 0.00% from $4,000 recorded in Q2 2014.
  • In the past 5 years, Abeona Therapeutics' Treasury Shares registered a high of $5.3 million during Q1 2025, and its lowest value of $61,108 during Q2 2022.
  • In the last 3 years, Abeona Therapeutics' Treasury Shares had a median value of $4,000 in 2014 and averaged $4,000.
  • Over the last 5 years, Abeona Therapeutics' Treasury Shares had its largest YoY gain of 4,099.62% in 2023, and its largest YoY loss of 52.77% in 2023.
  • Abeona Therapeutics' Treasury Shares (Quarterly) stood at $4,000 in 2011, then remained steady at $4,000 in 2012, then remained steady at $4,000 in 2013, then remained steady at $4,000 in 2014.
  • Its Treasury Shares was $4.1 million in Q3 2025, compared to $4.9 million in Q2 2025 and $5.3 million in Q1 2025.